PharmaRoth Labs, Inc. (ROTH)

[old biohf guy]

Again, more incorrect information. Insolvent is claimed repeatedly, but we both know this is incorrect. Insolvent means not being able to pay the bills. Insolvent has nothing to do with long term debt.

As for fraudulent, there is nothng to this and never has been on the part of Roth, but maybe the following is applicable:

Post #10714 is a general warning and does not apply to Roth and Sucanon. For the benefit of all readers, he is a link to the complete FDA article:

Consumer Updates > Beware of Illegally Marketed Diabetes Treatments
https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm361487.htm

As for the previous modified Consumer Reports article, basically FDA wording (ref post #4477) here is the complete article and link:

https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm361487.htm
http://www.consumerreports.org/cro/news/2013/07/diabetes-treatment-alternatives/index.htm

Here is the full Consumer Reports article. I have highlighted in bold red the omitted sentence.

Watch out for fake diabetes treatments
Published: July 31, 2013 08:00 AM

If you see products on store shelves that claim to treat, cure, or prevent diabetes and its complications, the Food and Drug Administration wants to you to beware: it warned 15 companies last week about the illegal marketing of certain diabetes products, including Glucocil, Glytain, ProBeta’s Gynmena Sylvestre, and Zostrix Joint and Arthritis Pain Relief Cream.
What can you do? Watch out for the following product types and their treatment claims:
• “Natural” supplements. We’ve warned consumers in the past about the dangers of supplements. Some drugs labeled as “natural” were found to contain pharmaceutical ingredients that may actually harm rather than help.
• Dietary supplements. These supplements claim to treat and even prevent diabetes. These products are not FDA approved and therefore cannot make such a claim.
• Online pharmacy drugs. Online suppliers are selling prescription drugs to people without a prescription. Unapproved versions of diabetes drugs are found on these pharmacy websites.
• Unapproved OTC medications. These drugs claim to relieve symptoms associated with diabetes, but are not approved by the FDA.
Besides potential harm from the various treatments, there is concern that using these products will prevent people from seeking medical treatment and FDA-approved drugs.
Here are three generic, low-cost options that our CR Best Buy Drug experts recommend you discuss with your doctor:
• Metformin and Metformin Sustained Release (alone or with glipizide or glimepiride)
• Glipizide and Glipizide Sustained release (alone or with metformin
• Glimepiride (alone or with metformin)
In addition to taking medicine, it’s important to closely monitor your blood sugar. In our tests of blood glucose meters, the Accu-Chek Aviva and the FreeStyle Freedom Lite were two that came out on top. Results from blood glucose meters can help patients make adjustments to diet, exercise, and treatment plans. Close monitoring can help to lower the risk of diabetes-related issues, such as kidney disease and seizures.
Although there are no reported injuries yet, according to the FDA, the agency urged people who have experienced any side effects to report them through an online form.
— Ciara Rafferty

As for post #10707, here is the truth:

You state that "Sales are down around 90% in Mexico (last quarter, another losing quarter they did a whopping 20k in sales!)"

Instead of just a snippit of information, lets take a look at the entire picture.

Sales (total revenue)

Annual (period ending)
6/30/16.....263k
6/30/15......86k
6/30/14.....529k
6/30/13.....153k

Quarterly (period ending)
3/31/17......21k
12/31/16....124k
9/30/16......36k
6/31/16......25k
3/31/16......77k
12/31/15.....70k


Looking closely at the data, one can see that yes, there was a large decline from the 12/31/16 quarter (124k) to the 3/31/17 quarter (21k). This is an 83% decline from the previous quarter. I presume this is supposed to be the 90% decline figure, but its not quite correct. Looking closer at the quarterly sales, one can see that the 124k is very large compared to the other quarterly sales, so the decline looks worse than it really is. Maybe a better measure is to average the 124k and the 21k? The average is 72.5k.

For fiscal year 2017, 2 quarters are reported with sales of 21k and 124k for a total of 145k. Assuming the same sales pace for the 2nd half of 2017, this would result in 290k sales for FY 2017.

Compare the 290k projection for 2017 with the previous 4 years:
2016 - 263k
2015 - 86k
2014 - 529k
2013 - 153k

The previous post would have you believe that sales are tanking when in fact they are holding pretty steady. The devil is in the details, so I encourage everyone to look closely at the details and to always consider the source of the posted information.

All data above is easily available on OTC Markets.


In post #10707 it is stated that Roth is insolvent. All bills are being paid and Roth therefor is not insolvent.

In post #10712 all 15 items have been debunled many times.